This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This allows for streamlined regulatory processes and a reduced administration load for both pharmaceuticalcompanies and health authorities, according to the paper. The associations explained this is enabled through multi-country packs which are simplified by the language exemption and harmonised labelling requirements.
We revisit a favorite topic, sustainability—and will be updating our coverage of this topic with the upcoming March-April 2023 issue of Pharmaceutical Engineering. It is the result of more than two years of collaboration between the company corporate teams, individual site teams, and an external specialist consultant.
Indeed, a key aspect of EU GMP Annex 1 is the requirement for pharmaceutical manufacturers to develop a comprehensive Contamination Control Strategy (CCS) that documents their approach to assuring the sterile drug product’s high quality and, therefore, enhancing patient safety. Register your details to read more The post How ready are you?
In this article, we’ll explore 10 innovative trends in pharma marketing that can set you up for success in this rapidly evolving landscape. From eco-friendly packaging to socially responsible campaigns, sustainability resonates with today’s consumers. Learn more about compliance tips at Pharma Marketing.
On- or in-dose authentication means that a security measure or anticounterfeit feature is integrated with the dosage form itself, offering product verification and traceability embedded into each medicine, rather than on the secondary package” WHO estimates that >50 percent of the drugs for sale on the internet are fake.
In this article, Ben Hargreaves looks at how VR headsets are being used to better educate both healthcare professionals and the general public. This has not escaped the notice of pharmaceuticalcompanies looking to educate patients on topics, with which they may not have the most health literacy. In reality.
In a survey conducted by The European Consumer Organisation (BEUC) during June and July 2022, in Belgium, Italy, Portugal and Spain, 79 percent of consumers said paper leaflets should be available inside the package even if there is an alternative QR code on it. 11 This requirement directly contradicts what is included in Article 63.
The ERA therefore needs teeth – which does not mean it should be a barrier to the authorisation of new medicines – but it should require pharmaceuticalcompanies to minimise harmful effects on the environment, which indirectly also harm our health. Internet] Berlin: Centre for Planetary Health Policy. Available from: [link].
Applying what has been learned over the last three years to update pharmaceuticalcompanies’ approaches to development and implementation is key as the industry crafts its strategies in an increasingly digital and global environment. President, U.S. Business Unit and U.S. Country Head.
Compounded semaglutide is made by special compounding pharmacies rather than pharmaceuticalcompanies. In this article, well take a closer look at semaglutide, its costs, and alternatives that may be offered. Learn more from our article on how to get Wegovy covered by insurance. Does insurance cover Rybelsus?
This article reviews two case studies that cover sustainable pack types and extension of shelf life. Case Study One: Packaging Materials The first case study looks at developing more sustainable packaging materials and reducing the size of packaging materials. Let’s use the example of the packaging for medicines.
This article explores just one aspect of the RMP, that of RMMs, and how their effectiveness is measured with Dr Sophie Jouaville, an associate principal at IQVIA working on the design and oversight of non-interventional real-world evidence (RWE) safety and health economics and outcomes research (HEOR) studies.
For example, a pharmaceutical brand can face increased acquisition costs if a supplier has not delivered on time. It also bears extra replacement expenses when drugs are discarded due to improper packaging. Technologies allow pharmaceuticalcompanies to collect and analyze a massive amount of data to ensure proper drug safety.
The same was true of another of the company’s products, Delsam Pharma Artificial Eye Ointment , which the company voluntarily recalled shortly after. “The FDA said Global Pharma failed to use adequate, tamper-evident packaging and distributed the drugs without proper preservatives.” Here’s the kicker.
The global pharmaceutical market is becoming more digitalized, insight-driven, and consumer-centric. In this article, we’ll focus on a pharmaceutical market in the APAC region, go through the differences between pharma in APAC and pharma in other parts of the world, and see the current state of the APAC pharma market.
The parties that benefit are the pharmaceuticalcompanies and the pharmacies. The losers are patients, insurance companies and the country as a whole for wasting money on unneeded things. Medications are expensive, and some people throw them away after a year, even though they still might be good.
All traditional small molecule pharmaceuticals include carbon building blocks – by definition, organic materials – which are then transformed via modern synthetic chemistry to assemble the complex and highly variable skeletons that the final target structures demand. However, it is already clear that the investments will be gargantuan.
In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. The post What can pharma marketing learn from other regulated industries? appeared first on.
In an era when the world is accelerating the development of drugs and targeted medicines using innovative technologies, pharmaceuticalcompanies still face registration hurdles for well-characterized molecules because of redundant or additional local regulatory requirements.
3 , 4 Most companies have some existing initiatives underway, but many do not yet have a fully comprehensive and integrated program. This article explores effective management and oversight processes for accelerated delivery of large-scale programs of work.
Pharmaceuticalcompanies rely on AVI to overcome challenges associated with manual inspection, such as low inspection throughput and performance variations. Glass ampoules, as illustrated in Figure 1, offer protection against air and contaminations and are widely used as the primary packaging for pharmaceutical drugs.
link] A recent study published by My Green Lab 2 presented data from 74 biotechnology and pharmaceuticalcompanies tracking the change in scope 1, 2, and 3 carbon intensity (measured in tons of CO2 emitted vs. the company’s revenue in USD) since 2015. For pharmaceuticalcompanies, purchased goods (e.g.,
Within pharma and healthcare, where greater representation has been proven to lead to better health outcomes for all patients and the pharmaceuticalcompanies developing medicines, change is also happening. As a Non-Clinical Assessor at MHRA he assessed non-clinical data packages for new and generic medicines. About the authors.
3] You can learn more about the HPA axis and adrenals here in the linked article. Follow package instructions. Follow package directions for each supplement. Doses of 300 mg are generally enough for everyday support, but you may wish to increase your dose for the situations listed above, per package instructions.
This article provides a review on the current state of CM implementation, offers insights into life cycle management and regulatory aspects, and explains how a data- and knowledge-centric approach to risk management can help CM achieve its full potential. Even if regulators agree, the risk of a delay is enough to break a business case.
In this article, we describe the assessment of lag time for global regulatory approvals of postapproval CMC changes for multiple products over a three-year period. Consequently, comparing results across companies and through time will establish an increasingly robust perspective of trends in global approval durations.
This article dives deep into how patient marketing has changed, whats driving this transformation, and what strategies are leading the way for 2025 and beyond. Additionally, integrating offline and online experiencessuch as QR codes on packaging leading to mobile resourcesenhances the continuity of care.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content